Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine
- 31 December 1985
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 5, 273-279
- https://doi.org/10.1016/s0166-3542(85)80038-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- IMMUNOGENICITY OF RECOMBINANT HEPATITIS B VACCINEThe Lancet, 1985
- Safety of the Hepatitis B VaccineNew England Journal of Medicine, 1985
- IMMUNOGENICITY OF RECOMBINANT YEAST HEPATITIS B VACCINEThe Lancet, 1985
- CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINEThe Lancet, 1984
- Human hepatitis B vaccine from recombinant yeastNature, 1984
- Hepatitis B surface antigen (HBsAg) subtype‐specific antibodies in persons vaccinated against hepatitis BJournal of Medical Virology, 1984
- Hepatitis B Vaccine in Medical Staff of Hemodialysis UnitsNew England Journal of Medicine, 1982
- Synthesis and assembly of hepatitis B virus surface antigen particles in yeastNature, 1982
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981
- Viral hepatitis, type B, in experimental animalsThe American Journal of the Medical Sciences, 1975